All relevant data are available in the manuscript.

Introduction {#sec006}
============

Vesicovaginal fistula (VVF) is an abnormal fistulous tract extending between the bladder and the vagina that allows the continuous involuntary discharge of urine into the vaginal vault. In addition to the medical sequelae from these fistulas, they affect physical, mental, social and sexual life of the patients \[[@pone.0171554.ref001]\]. In developing countries, the predominant cause of VVF is prolonged obstructed labour (97%) \[[@pone.0171554.ref001]\]. Conversely, in industrial countries iatrogenic injury to the urinary tract is the most common cause of VVF and the majority are consequences of benign gynaecological surgery \[[@pone.0171554.ref002]\]. It is estimated that 0.8 per 1000 of all hysterectomies are complicated by the development of a VVF \[[@pone.0171554.ref003]\]. Other causes in the developed world include malignant disease and pelvic irradiation \[[@pone.0171554.ref004]\]. In contrast to obstetric and irradiation fistulas, the typical postsurgical (post hysterectomy) fistula is the result of more direct and localised trauma to healthy tissue \[[@pone.0171554.ref005]\].

Although vesicovaginal fistulas (VVF) are the most commonly acquired fistulas of the urinary tract, we lack a standardized algorithm for their management \[[@pone.0171554.ref006]\]. Conservative management including prolonged bladder drainage, glue/fibrin injections, fulguration and so on is a reasonable option in cases with small, clean and non-malignant VVF \[[@pone.0171554.ref003],[@pone.0171554.ref007]\]. Beside that, an operation is by far the most commonly preferred approach for affected women and the success rate varies between 75--95% with various different techniques in literature \[[@pone.0171554.ref003],[@pone.0171554.ref008]--[@pone.0171554.ref013]\]. Multiple different surgical routes like Latzko repair, open transabdominal, transvaginal, laparoscopic, robotic, transurethral endoscopic with or without tissue interposition have been described \[[@pone.0171554.ref008],[@pone.0171554.ref009],[@pone.0171554.ref013]\], but no studies have compared surgical with conservative procedures and their outcomes in patients with VVFs following benign gynaecologic surgery. Furthermore, there is no general consensus regarding surgical time for a successful repair \[[@pone.0171554.ref007]\]. However, the evidence concerning treatment outcome with well-documented success and complication rates as well as the optimal surgical timing is lacking. To our knowledge, this is the first systematic review and meta-analysis investigating this topic. Primary outcome of interest was to review and summarize the current body of literature regarding effectiveness of disease management in patients with VVF following benign gynaecologic surgery. Our secondary objective was to define the most commonly reported time point for treatment and determine the types of study designs.

Materials and methods {#sec007}
=====================

This study was reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement \[[@pone.0171554.ref014]\]. Before data extraction, the protocol of this review was registered with the PROSPERO International Prospective Register of Systematic Reviews (CRD42012002097) following the PRISMA guidelines for protocols (PRISM-P) \[[@pone.0171554.ref015]\]. The following PICO question was defined and is shown in [Fig 1](#pone.0171554.g001){ref-type="fig"}.

![PICO question.](pone.0171554.g001){#pone.0171554.g001}

Literature search {#sec008}
-----------------

Literature search included 4 data sources using the retrieval systems DIMDI Classic search or OvidSp. In detail, we performed a computerised English-language Medline, Pub med, Cochrane Central Register of Controlled trials (CENTRAL) and Embase literature search using the MeSH terms \*vesicovag\* AND \*fistul\* AND (\*management\* OR \*iatrogenic\* OR \*surgery\* OR repair\*), respectively. Our search ranged from 1947 to March 2016.

Study selection {#sec009}
---------------

The limits for literature search were adult human females. Studies were included if they reported on a) vesicovaginal fistula b) which occurred after a benign gynaecologic surgery c) with clearly described conservative or surgical management. In screening process we excluded studies focusing on other types of urogenital fistulas (UGF), congenital fistulas or fistulas due to malignancy/irradiation or foreign bodies. Studies dealing with obstetrical VVF or trials, which did not clearly separate outcome parameters regarding fistula cause, were also excluded. Congress proceedings of international society meetings, textbooks, and review articles did not meet the inclusion criteria. Reports including men, neonates or adolescents despite the search limits were not included. Non-English articles with English abstracts were included if they provided information not found in English-language literature.

Data extraction and study characteristics {#sec010}
-----------------------------------------

Two investigators (BBA and KB) independently reviewed random titles and abstracts to establish reliable, reproducible inclusion criteria. All pertinent references from the manuscripts were obtained and reviewed. General characteristics were recorded from each study. Two authors (BBA and KB) independently abstracted study design, number of included patients, type or size of the VVF, different types of treatment (surgical/conservative), route and type of surgical treatment, cause of fistula and time point of surgical repair. The following outcome parameters were measured: time between fistula occurrence and repair (= surgical time), complete resolution of symptoms, success rate and treatment complications: postoperative leakage, de-novo stress incontinence, de novo urgency, urinary tract infection, number of attempts/repair, new-onset of pain/dyspareunia, recurrent VVF immediately (failure) or at any time postoperatively and long-term consequences on pelvic health including sexual function immediately or at any time after treatment. Terminology for success was inconsistent among included studies. We used terminology for success when success was either defined as "anatomical cure--fistula closed, healed or cured" or "absence of urinary loss, resolution of symptoms". A total of 12 publications showed disagreement between the two reviewers. This was resolved by discussion with a third person (EH or HK). The findings of all relevant studies were abstracted, categorized and summarized by study design and outcomes measured. Furthermore, two of the authors (BBA and KB) independently rated the quality of the studies, using criteria from US Preventive Services Task Force and the NHS Centre for Reviews and Dissemination \[[@pone.0171554.ref016]\]. Studies received a poor rating if they were case reports, case series without adequate control group or comparative studies where the groups were not comparable.

### Risk of bias (RoB) assessment {#sec011}

Risk of bias between included studies was independently assessed and evaluated by two of the authors (BBA and KB). Due to the types of study design of included studies the Newcastle Ottowa Scale for risk of bias assessment for comparative studies was used ([Table 1](#pone.0171554.t001){ref-type="table"}) \[[@pone.0171554.ref017]\]. This considers 3 criteria (selection of study groups, comparability of groups and ascertainment of outcome of interest) for quality assessment. Discrepancy between the review authors over the risk of bias was resolved by discussion, with involvement of a third author where necessary.

10.1371/journal.pone.0171554.t001

###### Quality assessment (Newcastle Ottowa Scale) for comparative studies.

![](pone.0171554.t001){#pone.0171554.t001g}

  Author, year            Selection                                   Comparability                             Outcome/Exposure
  ----------------------- ------------------------------------------- ----------------------------------------- -------------------------------------------
  Gupta N, 2010           [\*\*\*](#t001fn004){ref-type="table-fn"}   [\*](#t001fn002){ref-type="table-fn"}     [\*\*\*](#t001fn004){ref-type="table-fn"}
  Ou CS, 2004             [\*\*\*](#t001fn004){ref-type="table-fn"}   [\*\*](#t001fn003){ref-type="table-fn"}   [\*\*\*](#t001fn004){ref-type="table-fn"}
  Pshak T, 2013           [\*\*](#t001fn003){ref-type="table-fn"}     [\*](#t001fn002){ref-type="table-fn"}     [\*\*\*](#t001fn004){ref-type="table-fn"}
  Rajamaheswari N, 2012   [\*\*\*](#t001fn004){ref-type="table-fn"}   [\*\*](#t001fn003){ref-type="table-fn"}   [\*\*\*](#t001fn004){ref-type="table-fn"}
  Miklos JR, 2015         [\*\*](#t001fn003){ref-type="table-fn"}     [\*](#t001fn002){ref-type="table-fn"}     [\*\*](#t001fn003){ref-type="table-fn"}

A study can be awarded a maximum of one star for each numbered item within the selection and outcome categories. A maximum of two stars can be given for comparability.

\*: poor quality

\*\*: moderate quality

\*\*\*: high quality

Synthesis of results {#sec012}
--------------------

The meta-analysis was conducted on individual patient level using random-effect logistic regression models to calculate the probability of success for every type of therapy (conservative, surgical, combined) and every route and type of surgical treatment. 95% confidence intervals for the estimated proportion of successful treatments were calculated based on profile likelihood. To show the amount of heterogeneity the between trial variance τ² is presented for every model. Random- effects logistic regression models were used to manage study heterogeneity. Furthermore, calculation of the meta-analysis was also extended to random-effect logistic regression models. No odds ratios for the comparison between the different types of therapy were calculated as only 4 out of the 124 trials had a comparative study design while 120 studies reported uniform treatment for all documented patients. Therefore the differences in the outcome might be mainly influenced by the heterogeneity of the study populations. All statistical calculations were performed using the R-project for statistical computing (Version R-3.2.5) \[[@pone.0171554.ref018]\].

Results {#sec013}
=======

We identified 2165 citations, reviewed 282 full text articles, and identified 124 studies for inclusion \[[@pone.0171554.ref001],[@pone.0171554.ref004],[@pone.0171554.ref008],[@pone.0171554.ref010],[@pone.0171554.ref013],[@pone.0171554.ref019]--[@pone.0171554.ref137]\]. We excluded 1018 studies because they did not meet the inclusion criteria. The results of the search and screening procedure are presented as a PRISMA Flow Chart in [Fig 2](#pone.0171554.g002){ref-type="fig"}. The final analysis included 23 case reports, 95 retrospective case series, 5 comparative studies and 1 uncontrolled prospective study involving 1430 patients in all. There were no randomized controlled trials and no case-control studies. Case series contained between 2 and 110 patients. Detailed information of each included study (author, year, type of procedure and success rate) is summarized in [Table 2](#pone.0171554.t002){ref-type="table"}.

![PRISMA Flow Chart.](pone.0171554.g002){#pone.0171554.g002}

10.1371/journal.pone.0171554.t002

###### Included studies, type of procedure/approach and reported success rates.

![](pone.0171554.t002){#pone.0171554.t002g}

  Author, year                   Type of procedure                    sucess rate(%)
  ------------------------------ ------------------------------------ -----------------------------
  Ansquer et al, 200618          transvaginal                         100%
  Abdel-Karim et al, 201119      Laparoscopic                         100%
  Ayed et al, 200620             combined vaginal and suprapubic      41%
  Aycinena et al, 197721         conservative (curretage)             100%
  Agrawal et al, 201522          Robotic                              100%
  Blandy et al, 199123           Transabdominal                       100%
  Badenoch et al, 198724         Transabdominal                       100%
  Baumrucker et al, 197125       rubber ball                          not stated
  Bramhall et al., 195026        Transabdominal                       not stated
  Bajory et al, 201127           Transvaginal                         100%
  Brandt et al, 199828           Transvesical                         96%
  Bragayrac et al, 201429        Robotic                              not stated
  Clark et al, 197530            combined vaginal and transvesical    100%
  Chibber et al, 200531          Laparoscopic                         100%
  Chien W-H et al, 200632        Transvaginal                         100%
  Chapron et al, 199533          Transabdominal                       100%
  Cruikshank et al, 198734       Transvaginal                         82%
  Chu Lei et al, 201535          Laparoscopic                         100%
  Dogra Prem et al, 201136       YAG laser weldging                   88%
  Dorsey et al, 196037           Transabdominal                       100%
  Daley et al, 200638            conservative (fibrin sealant)        100%
  Dos Santos et al, 200839       Laparoscopic                         not stated
  Dorairajan et al, 200840       Transvaginal                         not stated
  Dalela et al, 200641           Transabdominal                       100%
  Ezzat et al, 2009 42           combined abdominal and vaginal       88%
  Falk et al, 1957 43            conservative (electrocoagulation)    100%
  Fourie et al, 198344           Transabdominal                       88%
  Flynn et al, 200445            Transvaginal                         100%
  Fearl et al, 196846            transvesical or transvaginal         90%
  Fang et al, 201547             transvaginal (with foley catheter)   100%
  Fleischmann et al, 198848      Transabdominal                       100%
  Gupta et al, 201049            transabdominal versus robotic        100%
  Gözen et al, 200950            Laparoscopic                         100%
  Goodwin et al, 198051          Transvaginal                         100%
  Grange et al, 201452           combined vaginal and vesicoscopic    100%
  Harrow et al, 196853           Transvesical                         not stated
  Hong HM et al, 201054          pointed electrocoagulation           100%
  Hessami et al, 200755          Transadominal                        100%
  Hellenthal et al, 200756       Transabdominal                       95%
  Hemal et al, 200857            Robotic                              100%
  Henriksson et al, 198258       combined vaginal and suprapubic      78%
  Hsieh CH et al, 200859         Transvaginal                         1005%
  Immergut et al, 195060         Transvesical                         67%
  Iselin et al, 199813           Transvaginal                         100%
  James et al, 201361            conservative (bladder drainage)      1005%
  Javali et al, 201462           Laparoscopic                         100%
  Kostakopoulos et al, 199863    transvaginal and transabdomnal       100%
  Krissi et al, 200164           fistulectomy & closure               not stated
  Keettel et al, 197865          transvaginal and combined            94%
  Kristensen et al, 66           Transabdominal                       not stated
  Ledniowska et al, 201267       transvaginal with modifications      not stated
  Lazarou et al, 200668          Transvaginal                         100%
  Llueca et al, 201569           Laparoscopic                         100%
  Landes et al, 197970           Transvesical                         100%
  Dutto et al, 201371            Robotic                              1005
  Liao et al, 20124              Transvaginal                         83,30%
  Morgan et al, 195072           Transabdominal                       not stated
  DasMahapatra et al, 200773     Laparoscopic                         100%
  Modi et al, 200674             Laparoscopic                         100%
  Muto et al, 200575             conservative (glue)                  66.6%
  El-Lateef et al, 200376        Retropubic                           100%
  McKay et al, 200177            Cystorrhaphy                         not stated
  Milicic et al, 200178          Transvaginal                         95.2%
  McKay et al, 199779            Cystorrhaphy                         100%
  Miklos et al, 199980           Transvaginal                         not stated
  Malin et al, 196781            gold leaf                            not stated
  Moriel et al, 199382           Transvesical                         100%
  Mohseni et al, 201283          Transabdominal                       86%
  Macalpine et al, 194084        Transvesical                         100%
  Malmström et al, 195585        Conservative                         100%
  Mallikarjuna et al, 201586     laparoscopic (AINU)                  100%
  Miklos et al, 201587           Laparoscopic                         97%(primary)100%(recurrent)
  Nagraj et al, 200788           Laparoscopic                         not stated
  Nabi et al, 200189             Laparoscopic                         100%
  Nesrallah et al, 199990        Transabdominal                       100%
  Nezhat et al, 199491           Laparoscopic                         100%
  Nerli et al, 201092            Transvesicoscopic                    100%
  Otsuko et al, 200893           Laparoscopic                         not stated
  Ou et al, 200410               combined /vag./abd./laparosc.)       83%/100%/100%
  Ostad et al, 199894            Transabdominal                       100%
  Phipps et al, 199695           Laparoscopic                         100%
  Persky et al, 197996           Transvesical                         83%
  Pietersma et al, 201497        Robotic                              100%
  Persky et al, 197398           Transabdominal                       100%
  Pontes et al, 197499           Transabdominal                       100%
  Peikoff et al, 1956100         Transabdominal                       100%
  Phsak et al, 2013101           Transvaginal                         not stated
  Rizvi et al, 2010102           Laparoscopic                         100%
  Reynolds et al, 2008103        Transabdominal                       100%
  Radopoulos et al, 2008104      Transvaginal                         100%
  Raz et al, 19938               Transvaginal                         82%
  Roslan et al, 2012105          LESS                                 100%
  Razi et al, 2015106            combined(transvag./transabd.)        100%
  Rader et al, 1975107           Transvaginal                         100%
  Rajamaheswari et al, 2012108   transvag. versus transabd.           95% vs.100%
  Szendi et al, 1959109          Transvaginal                         100%
  Schneidermann et al, 1958110   Suprapubic                           100%
  Shah et al, 2010111            conservative (fulguration)           not stated
  Roen et al, 1960112            combined (transvag.,transvesic.)     not stated
  Robles et al, 2009113          Transvaginal                         not stated
  Schimpf et al, 2007114         Robotic                              100%
  Sears et al, 2007115           Robotic                              100%
  Sundaram et al, 2006116        Robotic                              100%
  Starkman et al, 2007117        Transvaginal                         100%
  Singh RB et al, 2005118        Transabdominal                       100%
  Soong et al, 1997119           Transabdominal                       67%
  Sharma et al, 20141            Laparoscopic                         100%
  Singh V et al, 2013120         Laparoscopic                         100%
  Shirvan et al, 2013121         conservative (plasma/glue)           100%
  Simforoosh et al, 2012122      Laparoscopic                         75%
  Sharifiaghdas et al, 2012123   Transabdominal                       90%
  Singh et al, 2012124           Transabdominal                       89%
  Tancer et al, 1992125          Transvaginal                         89%
  Toledo et al, 2013126          Observation                          100%
  Tsivian et al, 2006127         Transvaginal                         100%
  Tiong et al, 2007128           Laparoscopic                         100%
  Theobald et al, 1998129        Laparoscopic                         100%
  Taylor et al, 19481230         Transvesical                         100%
  Udea et al, 1977131            Suprapubic                           100%
  Wong et al, 2006132            Laparoscopic                         100%
  Wein et al, 1980133            Transabdominal                       91%
  Xu et al, 2005134              Transabdominal                       100%
  Zhang et al, 2013135           Laparoscopic                         100%
  Zumrutbas et al, 2014136       Cystoscopy                           100%
  Transvag.: transvaginal        transabd.: transabdominal            transvesic.: transvesical

Study characteristics {#sec014}
---------------------

Fistula type was documented only in 58/124 (47%) studies. Of these, the majority of trials 35/58 (60%) dealed with simple fistulas, 21/58 (36%) with complex VVF and in a small percentage of studies (4%) complicated VVF were investigated. The majority of studies (66/124; 53%) did not comment on fistula type. Mean fistula size could not be calculated due to heterogeneity and insufficiency of data documentation. The majority of VVF occurred after a transabdominal hysterectomy (n = 943/1430; 66%), followed by vaginal hysterectomy (n = 126/1430; 9%), laparoscopic hysterectomy (n = 38/1430; 3%) and other benign gynaecologic operations (n = 72/1430; 5%). The remaining studies (17%) did not mention the type of hysterectomy causing the fistula. 46/124 (37%) studies included only patients who underwent a primary fistula repair (n = 221), 16/124 (13%) studies investigated patients who had previous attempts of fistula repair (n = 54) and 41/124 (33%) trials described a mixed collective of cases (n = 979). Remaining 21 studies (17%) did not give any information. Number of attempts varied between 1 and 3 repairs in average.

Conservative treatment: Results of individual studies {#sec015}
-----------------------------------------------------

10 studies described non-surgical treatment strategies as sole treatment option. These included transvaginal injection of fibrin sealant in 1 case, Yag Laser welding in 8 patients, cystoscopic electrocoagulation/fulguration/catheter method in 11 patients, endovaginal application of cyanoacrylic glue in 3 cases, platelet rich plasma/rich fibrin glue application in 6 women, curettage of fistula tract in 3 cases and ball technique with rubber/metal ball in 18 females. Success ranged between 67%-100% and the majority consisted of small VVF (\<1 cm) \[[@pone.0171554.ref022],[@pone.0171554.ref026],[@pone.0171554.ref037],[@pone.0171554.ref039],[@pone.0171554.ref044],[@pone.0171554.ref062],[@pone.0171554.ref076],[@pone.0171554.ref086],[@pone.0171554.ref112],[@pone.0171554.ref122]\].

239/1430 VVF (16%) were initially managed conservatively with prolonged catheter drainage (range: 2--12 weeks). Only 19/239 (8%) VVFs resolved with catheter drainage and the remaining 220/239 (92%) VVFs underwent surgical repair.

Surgical treatment {#sec016}
------------------

The majority of patients were treated surgically. In all, 1379 patients were managed surgically and 97.98% (95%-CI: 96.13--99.29) were cured. The most commonly reported surgical approach was the transvaginal route (n = 534/1379; 39%), followed by a transabdominal/transvesical approach (n = 493/1379; 36%), a laparoscopic/robotic route (n = 207/1379; 15%) and a combined transabdominal-transvaginal approach in 45/1379 (3%) cases. Additionally, further various surgical techniques like transvaginal transurethral pointed electrocoagulation, transurethral suture cystorraphy, suprapubic cystotomy with gold leaf and so on were reported in 41/1379 (3%) cases. In 59/1379 (4%) VVFs the surgical route was not documented. Interposition grafts like Martius flap, Gracilis muscle, omental, peritoneal, labial fat flap or bladder mucosa autograft were used in the majority of studies (66 studies including 708 cases).

Success after treatment {#sec017}
-----------------------

107/124 (86%) studies documented a success rate after treatment, describing 87 patients being completely symptom-free, 754 being completely dry and in 406 cases fistula healed completely or was cured.

### Results of each meta-analysis with logistic regression model {#sec018}

Only studies which consistently evaluated treatment success were used for the meta-analysis. Success rate of conservative treatment was 92.86% (95%CI: 79.54--99.89), 97.98% in surgical cases (95% CI: 96.13--99.29) and 91.63% (95% CI: 87.68--97.03) in patients with prolonged catheter drainage followed by surgery. Success rates regarding surgical approaches were as follows: transabdominal/transvescial route 97.05% (95% CI: 94.55--99.18), transvaginal route 93.82% (95% CI: 89.96--97.49), laparoscopic/robotic approach 98.87% (95% CI: 96.85--99.99) and combined transabdominal/transvaginal route 90.70% (95% CI: 64.63--99.87). Use of interposition flap showed a success rate of 97.63% (95% CI: 95.31--99.22), without interposition flap reported success rate was 97.62% (95% CI: 93.63--99.91).

Reported frequency of success rates are summarised in Tables [3](#pone.0171554.t003){ref-type="table"}--[8](#pone.0171554.t008){ref-type="table"}.

10.1371/journal.pone.0171554.t003

###### Treatment modalities.

![](pone.0171554.t003){#pone.0171554.t003g}

  Treatment            conservativ      surgcial            Catheter and surgery
  -------------------- ---------------- ------------------- ----------------------
  Number of studies    9 81,8% of 11    73 89,0% of 82      25 80,6% of 31
  Number of patients   28 54,9% of 51   983 90,3% of 1088   239 82,1% of 291

10.1371/journal.pone.0171554.t004

###### Frequency of success.

![](pone.0171554.t004){#pone.0171554.t004g}

                     Estimated proportion of successes %   95%-CI of proportion of successes   Between trial variance τ²
  ------------------ ------------------------------------- ----------------------------------- ---------------------------
  Conservative       92,86                                 79,54--99,89                        0
  Surgical           97,98                                 96,13--99,29                        2,05
  Catheter+surgery   91,63                                 87,68--97,03                        0

10.1371/journal.pone.0171554.t005

###### Surgcial approaches.

![](pone.0171554.t005){#pone.0171554.t005g}

  Surgical approach    Abdominal   transvaginal   Laparosc.or robotic   Others   combined   n.s.
  -------------------- ----------- -------------- --------------------- -------- ---------- ------
  Number of patients   493         534            207                   41       45         59

10.1371/journal.pone.0171554.t006

###### Frequency of success.

![](pone.0171554.t006){#pone.0171554.t006g}

                           Estimated proportion of successes %   95%-CI of proportion of successes   Between trial variance τ²
  ------------------------ ------------------------------------- ----------------------------------- ---------------------------
  Abdominal/transvescial   97,05                                 94,55--99,18                        0,49
  Transvaginal             93,82                                 89,96--97,49                        0,19
  Laparoscopic/robotic     98,87                                 96,85--99,99                        0
  Others                   100                                                                       
  Combined                 90,70                                 64,63--99,87                        2,65

n.s: not stated

Laparoscp.: laparoscopic

10.1371/journal.pone.0171554.t007

###### Use of interposition flap.

![](pone.0171554.t007){#pone.0171554.t007g}

  Interposition Flap   Without             with
  -------------------- ------------------- -------------------
  Number of studies    21 72,41% of 29     62 93,94% of 66
  Number of patients   217 64,98% of 334   695 98,16% of 708

10.1371/journal.pone.0171554.t008

###### Frequency of success.

![](pone.0171554.t008){#pone.0171554.t008g}

                 Estimated proportion of successes %   95%-CI of proportion of successes   Between trial variance τ²
  -------------- ------------------------------------- ----------------------------------- ---------------------------
  With Flap      97,63                                 95,31--99,22                        1,594
  Without Flap   97,62                                 93,63--99,91                        2,034

Intra- and postoperative surgical outcome {#sec019}
-----------------------------------------

Successful intraoperative or postoperative outcome was mentioned in detail in 78/124 (63%) studies. The majority of these studies defined a successful outcome as an uneventful intra- or postoperative course and no immediate complications detected. 14 studies mentioned a complicated postoperative outcome and in 24 patients this was described in detail: ileus (n = 5), postoperative fever (n = 6), intraoperative bleeding (n = 2), grad II hydroureter (n = 1), clostridium difficile atelectasis (n = 1), wound infection (n = 2), bowel injuries (n = 2), compartment syndrome (n = 1), pelvic abscess (n = 1), and occurrence of ureterovaginal (n = 1) and vesicocolonic fistula (n = 2).

Length of follow-up and complication rates {#sec020}
------------------------------------------

79/124 (64%) studies provided information for the length of follow-up. The remaining 45 studies did not mention any length of follow-up. The mean available follow-up time was 19.7 months. Complications were studied only selectively. Total number of studies mentioning complication outcome is shown in [Table 9](#pone.0171554.t009){ref-type="table"}. Due to the inconsistency of these data it was impossible to analyse them collectively.

10.1371/journal.pone.0171554.t009

###### Number of studies mentioning complication outcome.

![](pone.0171554.t009){#pone.0171554.t009g}

  Complications        Mentioned in Studies   Patients in these studies   Observed absolute frequency   Observed relative frequency
  -------------------- ---------------------- --------------------------- ----------------------------- -----------------------------
  Failure/Recurrence   60                     905                         59                            6,52%
  UTI                  15                     229                         12                            5,24%
  De novo SUI          26                     247                         5                             2,02%
  De novo pain         5                      72                          1                             1,39%
  De novo urgency      32                     280                         10                            3,57%

Long-term consequences and sexual function after treatment {#sec021}
----------------------------------------------------------

None of the included studies documented any long-term consequences of pelvic health. Only 3 studies assessed sexual function after treatment \[[@pone.0171554.ref041],[@pone.0171554.ref093],[@pone.0171554.ref135]\]. Dorairajan et al. reported that 8/10 patients were sexual active without any signs of dyspareunia or pain \[[@pone.0171554.ref040]\], Nerli et al. reported that 2/4 cases were sexual active and all 3 women were sexual active in the study published by Xu et al. \[[@pone.0171554.ref093],[@pone.0171554.ref135]\].

Surgical time: Time between fistula occurrence and repair {#sec022}
---------------------------------------------------------

In 22/124 (18%) studies, including 241 patients, surgery was initiated \< 12 weeks after fistula occurrence. 15/124 (12%) studies with 223 patients defined the time point of surgical repair after 12 weeks. No statistically significant difference regarding success rate could be detected between early and late repair (p\>0.05). 11 (9%) studies (n = 147 cases) started surgical timing \< 12 weeks as well as \> 12 weeks. The majority of studies (64/124; 52%), including 531 cases did not give any comment on their surgical time and 12 studies (9%) did not document an adequate time range.

Discussion {#sec023}
==========

Vesicovaginal fistulas are among the most distressing complications of obstetric and gynaecologic procedures, which can cause devasting medical, social, and psychogenic consequences \[[@pone.0171554.ref138]\]. The aetiology has changed, becoming more associated with hysterectomy. Despite numerous publications on this subject, the management of VVF remains a source of debate. The options of fundamental issues such as the preferred surgical approach and the optimal timing of surgery still vary widely \[[@pone.0171554.ref128]\].

Main findings {#sec024}
-------------

This systematic review and meta-analysis assessed the effectiveness of disease management in patients with postsurgical fistulas and investigated treatment outcome with success and complication rates as well as surgical timing and type of study designs. The scientific literature consists mainly of case reports and retrospective case series. Furthermore, this analysis contains only a minority of studies, which used conservative treatment options as sole fistula treatment, as the majority of patients were treated surgically (96.4%). The preferred surgical approach was a transvaginal route, followed by transabdominal/transvesical approach, laparoscopic/robotic approach and combined operation techniques with reported success rates of 93.82%, 97.05%, 98.87% and 90.70%, respectively.

Comparison with literature {#sec025}
--------------------------

Treatment of patients with VVF is currently controversial \[[@pone.0171554.ref139]\]. Although a trial of conservative management with prolonged bladder drainage might be tried, the spontaneous closure rate of VVF is low \[[@pone.0171554.ref051]\]. We found only 10 studies, which used conservative treatment as sole treatment strategy. Besides, our data confirmed that VVF resolves with prolonged catheter drainage only in a low percentage (8%). Some authors indicate that conservative treatment is only successful in smallest fistulas, and the majority of patients will require definitive surgical repair \[[@pone.0171554.ref003],[@pone.0171554.ref044],[@pone.0171554.ref140]\]. However, no studies exist comparing non surgical with surgical treatment strategies.

Although an operation is by far the most common recommendation for affected women, evidence concerning surgical treatment is lacking. Multiple different surgical techniques and approaches have been described in literature \[[@pone.0171554.ref008],[@pone.0171554.ref009],[@pone.0171554.ref013]\], but the choice mainly depends on location, severity and size of fistula \[[@pone.0171554.ref141]\]. Additionally, only few studies have compared the surgical procedures/approaches for VVF \[[@pone.0171554.ref010],[@pone.0171554.ref050],[@pone.0171554.ref102],[@pone.0171554.ref109]\]. One study compared open and robotic surgical repair in patients with recurrent VVFs with no significant difference in outcome and complication rate \[[@pone.0171554.ref050]\]. Ou et al. evaluated three different surgical techniques (laparoscopic--open abdominal--transvaginal) in patients with primary fistula repair. Their data suggested that laparoscopic repair is feasible and results in lower morbidity than transabdominal and vaginal repair \[[@pone.0171554.ref010]\]. Phsak et al. compared the outcome between recurrent VVFs and primary VVFs without tissue interposition. The authors concluded that transvaginal repair of recurrent VVFs without tissue interposition is equally successful as in primary repairs \[[@pone.0171554.ref102]\]. Rajamaheswari et al. investigated the outcome between vaginal and transabdominal repair and reported comparable success rates between the two groups \[[@pone.0171554.ref109]\].

### Surgical approach {#sec026}

The most important principle in repair is to provide tension-free, watertight closure, and the surgical route should be the one that provides the best possible chance of closure on the first attempt \[[@pone.0171554.ref142]\]. These principles can be achieved through a vaginal, abdominal or endoscopic approach. Although the choice of technique partly depends on the characteristics of the fistula, the surgical experience is also an important factor of successful outcome \[[@pone.0171554.ref138]\]. Although different surgical techniques have been described, a consensus for the ideal approach for surgical correction of VVF is still required \[[@pone.0171554.ref142]\].

### Vaginal approach {#sec027}

In general, most gynaecologic surgeons prefer the vaginal approach, which has been associated with lower morbidity rates and with an equally good outcome \[[@pone.0171554.ref007],[@pone.0171554.ref143]\]. The two most commonly reported vaginal repair techniques include Latzko technique and the layered closure \[[@pone.0171554.ref143]\]. This systematic review confirmed that vaginal fistula repair was used in the majority of cases with a reported success rate of 93.82%. Latzko operation was performed in 170 women and Tancer et al. published the largest investigation with 110 VVFs post hysterectomy. 107 patients were treated by partial colpocleises (Latzko repair) and 89% were cured at first attempt \[[@pone.0171554.ref126]\]. Although the included studies are inconsistent regarding characteristics of the fistula, we summarize that the vaginal approach for fistula repair is performed in the majority of female patients and therefore it is the surgical procedure with the highest level of experience in literature.

### Abdominal approach {#sec028}

The abdominal route can be performed using a transvesical or an extravesical (bivalve technique) approach and is mainly indicated for loculated or complex fistulas \[[@pone.0171554.ref143]\]. We included 439 cases managed with an abdominal/transvesical approach with a reported success rate of 97.05%. Majority of these cases were treated with interposition graft. Due to the inconsistency of included trials and lack of fistula characteristics no recommendation can be made.

### Laparoscopic and robotic-assisted approach {#sec029}

Minimally invasive laparoscopic surgery is increasingly being performed, including laparoscopic VVF repair \[[@pone.0171554.ref001],[@pone.0171554.ref010],[@pone.0171554.ref032],[@pone.0171554.ref036]\]. In 2005, Chibber et al. described a laparoscopic approach to the O\`Conor technique with reported advantages of decreased morbidity and a more rapid recovery \[[@pone.0171554.ref032]\]. One systematic review with 44 eligible studies compared the success rates between laparoscopic/robotic transvesical repair and extravesical laparoscopic repair techniques in patients with VVF. Due to their results, the authors summarized that extravesical VVF repair has similar cure rates compared to the traditional transvesical approach \[[@pone.0171554.ref144]\]. Most recent technology used in the treatment of VVF repair is the robotic-assisted approach and some authors reported excellent results with this operation technique \[[@pone.0171554.ref023],[@pone.0171554.ref030],[@pone.0171554.ref058],[@pone.0171554.ref098]\]. Disadvantages include increased learning curve, time, costs and surgeons experience. We included 8 studies, which used a robotic-assisted approach. Success rates were excellent with 100% success, but number of included patients was small. Summarizing our data, due to the small number (n = 26 cases in all) and heterogeneity of studies, no clear statement and recommendation can be made regarding this operation technique and their success and complication rate in fistula repair.

### Specified long-term outcome and complication rates {#sec030}

Postoperative complications are common and the most frequent postoperative complications reported in literature are de novo SUI, de novo urgency, leakage, de novo pain/dyspareunia, infection and failure \[[@pone.0171554.ref142],[@pone.0171554.ref143]\]. Analysing our data, we could demonstrate that the majority of the included studies did not mention an adequate follow-up time and complications were described only selectively. We summarised 106/124 papers mentioning any complication, but from the remaining studies, which did not mention it we cannot assume that none occurred. Due to the inconsistency of these data it was impossible to analyse them collectively and no accurate prediction of complication rates can be made.

### Surgical time {#sec031}

One of the main controversies in literature is the ideal timing for surgical intervention for postoperative VVF. Angioli et al. recommended waiting 2--4 months using continuous drainage of the bladder \[[@pone.0171554.ref143]\]. However, several other studies showed that, especially for small uninfected fistulae, early repair has better or at least similar success rates compared to delayed repair with additional advantage of reduced suffering and early commencement of normal life \[[@pone.0171554.ref024],[@pone.0171554.ref025],[@pone.0171554.ref143]\]. On the other hand, some reports indicate that timing of repair does not affect the outcome \[[@pone.0171554.ref145]\]. Our data demonstrated that 22 publications used an early repair, 15 studies started late surgical repair and 11 trials performed early as well as late repair. Due to this inconsistency, no serious recommendation can be done regarding ideal timing for surgical intervention.

### Definition success rate and fistula classification {#sec032}

The reported cure rate of VVF varies between 75--95% with various different techniques in literature \[[@pone.0171554.ref003],[@pone.0171554.ref008]--[@pone.0171554.ref013]\]. In accordance to literature, our findings revealed a success rate of 92.9% with conservative treatment, 97.98% in cases treated surgically and 91.63% in patients with prolonged catheter drainage followed by surgery. Summarising our data, no clear odds-on favorite regarding disease management as well as surgical approach could be identified and no technique was superior to any other. One major problem we faced was that success was defined in different ways, as many studies defined success as surgical closure of the fistula in place of function following surgery. In our opinion, successful surgical closure of the defect should be called 'anatomical closure' rather than 'cure', because many women suffer from on going pelvic organ, sexual and psychological dysfunction. Although this is of significant importance, only 3 studies \[[@pone.0171554.ref041],[@pone.0171554.ref093],[@pone.0171554.ref135]\] reported on sexual function after fistula treatment and the majority did not even mention this topic. Another problem that we faced when analysing the included studies was the lack of standardisation of terminology. The methodology of measuring the fistula as well as the used classification system was not clear in the majority of articles and none of the included studies stratified data by fistula type, primary repair versus previous attempts, fistula size or fistula location. Standardisation of the terminology is therefore required so that VVF can be properly managed \[[@pone.0171554.ref146]\]. Given the limitations of this analysis, future clinical research with a clearly defined VVF classification system, success definition better than anatomic result is needed to confirm our findings.

### Quality and design of studies included {#sec033}

The scientific literature regarding surgical or conservative management of VVF following a benign gynaecologic surgery in female patients includes mainly case reports and retrospective case series and a variety of different surgical techniques. For this reason the majority of the included studies received a poor quality rating due to the study type. Furthermore, the reporting standard regarding surgical outcome, follow-up time and complication rate was poor. In addition to differences in reporting, an adequate documented follow-up time was not mentioned in the majority of cases, making it difficult to draw meaningful conclusions from these findings.

Strengths and limitations {#sec034}
-------------------------

One of the strengths of our study is the inclusion of study data on the effectiveness of disease management in females with VVF in a specific population, namely after a benign gynaecologic surgery. The typical postsurgical fistula is the result of a direct and localised trauma to healthy tissue and therefore not comparable with obstetric or irradiation/cancer fistula. No similar analysis was found in literature. Besides, most of the included studies had the same primary outcome parameter, to be specific success after treatment. Limitations of our study are inherent to the limitations of the included studies. None of the included studies stratified data by fistula type, size or location. The methodology of measuring the fistula as well as the used classification system was not clear in the majority of articles. As no study reported data by using a unique classification system, a subgroup analysis according to fistula characteristics was not feasible. Another limitation arises from the study design as the majority of studies consisted of case reports or case series reporting uniform treatment for all documented patients. For this reason risk of bias assessment could be performed in a minority of studies with comparative study design. Furthermore, differences in outcome might be influenced by heterogeneity of study populations.

Conclusion {#sec035}
==========

Although the literature on disease management of females with postsurgical VVF is imprecise and inconsistent, our data show that the majority of patients are treated surgically through a transvaginal route. The quality and design of studies reviewed were weak with a poor reporting standard, weakening the conclusions that can be drawn. In summary, these data do not allow accurate prediction of success and complication rates in female patients with VVF following benign gynaecologic surgery. Standardisation of the terminology is required so that VVF can be managed with a proper surgical treatment algorithm based on characteristics of the fistula and well designed RCT are needed in future.
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